Li L, Mu K, Zhou G, Lan L, Auer G, Zetterberg A
Department of Pathology, Shandong University School of Medicine, Jinan, Shandong, People's Republic of China.
Br J Cancer. 2008 Aug 5;99(3):513-9. doi: 10.1038/sj.bjc.6604479.
The role of genomic instability and proliferative activity for development of distant metastases in breast cancer was analysed, and the relative contribution of these two risk factors was quantified. A detailed quantitative comparison was performed between Ki67 and cyclin A as proliferative markers. The frequency of Ki67 and cyclin A-positive cells was scored in the same microscopic areas in 428 breast tumours. The frequency of Ki67-positive cells was found to be highly correlated with the frequency of cyclin A-positive cells, and both proliferation markers were equally good to predict risk of distant metastases. The relative contribution of degree of aneuploidy and proliferative activity as risk markers for developing distant metastases was studied independently. Although increased proliferative activity in general was associated with an increased risk of developing distant metastases, ploidy level was found to be an independent and even stronger marker when considering the group of small (T1) node negative tumours. By combining proliferative activity and ploidy level, a large group of low risk breast tumours (39%) could be identified in which only a few percentage of the tumours (5%) developed distant metastases during the 9-year follow-up time period.
分析了基因组不稳定性和增殖活性在乳腺癌远处转移发生中的作用,并对这两个风险因素的相对贡献进行了量化。对作为增殖标志物的Ki67和细胞周期蛋白A进行了详细的定量比较。在428例乳腺肿瘤的相同显微镜视野中对Ki67和细胞周期蛋白A阳性细胞的频率进行评分。发现Ki67阳性细胞的频率与细胞周期蛋白A阳性细胞的频率高度相关,且这两种增殖标志物在预测远处转移风险方面同样有效。分别研究了非整倍体程度和增殖活性作为远处转移发生风险标志物的相对贡献。虽然一般来说增殖活性增加与远处转移发生风险增加相关,但在考虑小(T1)淋巴结阴性肿瘤组时,倍体水平是一个独立且更强的标志物。通过结合增殖活性和倍体水平,可以识别出一大组低风险乳腺肿瘤(39%),在9年的随访期内,其中只有少数百分比的肿瘤(5%)发生了远处转移。